SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Aspen Pharmacare Holdings Limited APNHF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • ZA • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Aspen Pharmacare Holdings Limited (APNHF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $8.69. It has a SharesGrow Score of 46/100, indicating a mixed investment profile with 0 out of 7 criteria passed.

Financials: revenue is $43.4B, +4.1%/yr average growth. Net income is $1.1B (loss), growing at -53.3%/yr. Net profit margin is -2.5% (negative). Gross margin is 44.1% (-3.3 pp trend).

Balance sheet: total debt is $36.1B against $84.9B equity (Debt-to-Equity (D/E) ratio 0.43, conservative). Current ratio is 2.21 (strong liquidity). Debt-to-assets is 26.6%. Total assets: $135.9B.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 30/100 (Fail), Past 75/100 (Partial), Health 67/100 (Partial), Moat 62/100 (Partial), Future ?/100 (Fail), Income 10/100 (Fail).

APNHF SharesGrow Score Overview

49/100

SharesGrow Score

Mixed signals — some strengths

View full scorecard →

VALUE 0/100

Valuation — P/E, PEG, Forward PEG

GROWTH 30/100

Financials — average growth

PAST 75/100

strong — trend

HEALTH 67/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 62/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 10/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — APNHF

No analyst coverage available for this stock.

APNHF: +4.1%/yr revenue is, -53.3%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

APNHF: 3 / 4 years profitable. mixed. Score = 3 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet APNHF: Debt-to-Equity (D/E) ratio 0.43 (conservative), Current ratio is 2.21 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

APNHF: Gross margin is 44.1% (-3.3 pp trend), $4B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 62/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

APNHF: Net profit margin is -2.5%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range6.23-12.245

Volume6.1K

Avg Volume (30D)218

Market Cap$3.86B

Beta (1Y)0.35

Dividend Yield$0.1218

Share Statistics

EPS (TTM)-2.44

Shares Outstanding$444M

IPO Date2010-04-29

Employees8,867

CEOStephen Bradley Saad

Financial Highlights & Ratios

Revenue (TTM)$43.36B

Gross Profit$19.13B

EBITDA$2.16B

Net Income$-1.08B

Operating Income$1.44B

Total Cash$6.41B

Total Debt$36.12B

Net Debt$29.71B

Total Assets$135.89B

Price / Earnings (P/E)-3.6

Price / Sales (P/S)0.09

Analyst Forecast

Company Info

CountryZA

ExchangeOther OTC

CurrencyUSD

ISINZAE000066692

Price Chart

APNHF

Aspen Pharmacare Holdings Limited ↗ · Other OTC

Healthcare • Drug Manufacturers - Specialty & Generic

6.23 52WK RANGE 12.25

People Also View

Antisense Therapeutics Limited

Crescita Therapeutics Inc.

Alterola Biotech, Inc.

The BC Bud Corporation

Aion Therapeutic Inc.

Amexdrug Corporation

Eli Lilly and Company

Johnson & Johnson

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message